Abstract
Efficacy and Safety of Ofatumumab and Bendamustine Followed By Ofatumumab Maintenance in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma after Prior Rituximab
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have